Cargando…
Implementing personalized medicine with asymmetric information on prevalence rates
Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions between pharmaceutical firms and healthcare sys...
Autores principales: | Antoñanzas, Fernando, Juárez-Castelló, Carmelo A., Rodríguez-Ibeas, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990530/ https://www.ncbi.nlm.nih.gov/pubmed/27539222 http://dx.doi.org/10.1186/s13561-016-0113-7 |
Ejemplares similares
-
Pre-approval incentives to promote adoption of personalized medicine: a theoretical approach
por: Antoñanzas, F., et al.
Publicado: (2019) -
Implementation of risk-sharing contracts as perceived by Spanish hospital pharmacists
por: Lorente, Reyes, et al.
Publicado: (2019) -
Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model
por: Antoñanzas, F., et al.
Publicado: (2021) -
Does diagnostic testing always decrease antibiotics prescriptions?
por: Antoñanzas, F., et al.
Publicado: (2022) -
Healthy vs. unhealthy food: a strategic choice for firms and consumers
por: Antoñanzas, Fernando, et al.
Publicado: (2011)